Watchlist Price Alert

Mainz Biomed B.V. (MYNZ)

NASDAQ: MYNZ · Real-Time Price · USD

2.47

-0.08 (-3.14%)

At close: May 09, 2025, 3:59 PM

2.43

-1.62%

After-hours: May 09, 2025, 05:59 PM EDT

Mainz Biomed B.V. Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019
Revenue	735.53K	714.97K	751.61K	529.88K	438.52K	577.35K	664.09K	493.56K	317.13K	140.7K	70.35K
Cost of Revenue	376.25K	396.84K	440.31K	347.73K	464.69K	399.73K	250.01K	370.48K	270.91K	171.33K	85.67K
Gross Profit	359.29K	318.13K	311.29K	182.15K	-26.18K	177.62K	414.08K	123.08K	46.22K	-30.64K	-15.32K
Operating Income	-16.4M	-19.57M	-25.25M	-26.17M	-23.37M	-9.71M	-418.9K	-356.3K	-366.02K	-375.74K	-187.87K
Interest Income	n/a	n/a	57.5K	289.32K	401.95K	339.17K	169.05K	n/a	n/a	n/a	n/a
Pretax Income	-16.21M	-18.31M	-25.63M	-26.39M	-25.31M	-11.67M	-534.2K	-586.89K	-532.71K	-478.53K	-239.26K
Net Income	-16.21M	-18.45M	-25.84M	-26.45M	-25.31M	-11.67M	-534.2K	-586.89K	-532.71K	-478.53K	-239.26K
Selling & General & Admin	11.37M	12.43M	17.41M	22.81M	22.38M	9.28M	525.13K	568.75K	472.3K	375.85K	187.93K
Research & Development	5.24M	7.25M	8.21M	3.66M	956.83K	466.69K	362.07K	311.85K	218.5K	125.16K	62.58K
Other Expenses	n/a	62.74K	-163.31K	-114.05K	122.75K	21.5K	26K	30.49K	19.19K	7.89K	3.94K
Operating Expenses	16.61M	19.74M	25.7M	26.36M	24.99M	11.32M	696.3K	911.09K	710K	508.9K	254.45K
Interest Expense	n/a	146.72K	436.04K	289.32K	84.79K	169.58K	219.19K	268.79K	184.88K	100.97K	50.48K
Selling & Marketing Expenses	3.61M	4.37M	5.22M	4.98M	3.69M	957.52K	205.53K	110.38K	100.56K	90.73K	45.37K
Cost & Expenses	17.13M	20.28M	26.14M	26.7M	25.45M	11.66M	665.68K	849.86K	683.15K	516.44K	258.22K
Income Tax Expense	n/a	146.72K	-66.42K	65.39K	363.32K	-409.39K	-475.08K	38.2K	18.19K	-1.82K	-909
Shares Outstanding (Basic)	558.75K	442.04K	29.38M	14.16M	13.82M	8.81M	12.01M	23.42M	23.42M	11.71M	11.71M
Shares Outstanding (Diluted)	558.75K	442.04K	29.38M	14.16M	14.29M	8.81M	12.01M	23.42M	23.42M	11.71M	11.71M
EPS (Basic)	-31.46	-12.63	-1.77	-1.87	-2.3	-1.32	-0.04	-0.05	-0.05	-0.04	-0.02
EPS (Diluted)	-31.46	-12.63	-1.79	-1.87	-2.28	-1.32	-0.04	-0.05	-0.05	-0.04	-0.02
EBITDA	-14.16M	-17.09M	-24.28M	-25.72M	-23.34M	-9.72M	-365.82K	-292.03K	-329.63K	-367.23K	-183.61K
EBIT	-14.74M	-4.93M	-12.2M	-26.1M	-23.37M	-9.72M	-254.63K	n/a	-188.78K	-377.56K	-188.78K
Depreciation & Amortization	743.3K	981.85K	979.11K	459.43K	26.76K	6.57K	47.87K	26.07K	18.2K	10.33K	5.17K